Understanding the complexities of Parkinson's Disease (PD) is crucial for healthcare professionals to provide effective care. This article provides a comprehensive overview of PD, its pathophysiology, diagnosis, treatment, and management.
The primary pathological characteristic of PD is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a decrease in striatal dopamine. This results in an imbalance in the basal ganglia circuitry, causing motor and non-motor symptoms.
PD diagnosis is primarily clinical, based on the presence of cardinal motor symptoms, including bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as olfactory dysfunction, REM sleep behavior disorder, and constipation may precede motor symptoms. Neuroimaging can provide supportive evidence but is not diagnostic.
The goal of PD treatment is to manage symptoms and improve quality of life. Pharmacological treatment primarily involves dopamine replacement with levodopa, dopamine agonists, and MAO-B inhibitors. Deep brain stimulation is an effective surgical treatment for selected patients.
Management of PD requires a multidisciplinary approach involving neurologists, physiotherapists, occupational therapists, and mental health professionals. Regular exercise and physiotherapy can help manage motor symptoms. Psychological support is essential due to the high prevalence of depression and anxiety in PD patients.
In conclusion, PD is a complex neurodegenerative disorder with a wide range of motor and non-motor symptoms. Accurate diagnosis, effective treatment, and comprehensive multidisciplinary management can significantly improve the quality of life for patients with PD. As healthcare professionals, it is crucial to stay updated on the latest advances in PD research and treatment to provide the best possible care.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation